mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.8 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |